electroCore (ECOR) Non-Current Debt (2020 - 2026)

electroCore (ECOR) posted Non-Current Debt of $5.8 million for Q2 2026, down 10.39% on a QoQ basis from $6.4 million in Q1 2026.

Analysis

electroCore (ECOR) Non-Current Debt (2020 - 2026) Analysis & Trends

electroCore has reported Non-Current Debt for 4 years, with the latest figure at $5.8 million in Q2 2026.

On a quarterly basis, Non-Current Debt changed N/A year-over-year to $5.8 million in Q2 2026; TTM through Jun 2026 was $5.8 million, a N/A change from a year earlier, with the FY2025 full-year figure at $6.6 million, changed N/A from the prior year.
Non-Current Debt was $5.8 million for Q2 2026 at electroCore, down from $6.4 million in the prior quarter.
The five-year high for Non-Current Debt was $6.6 million in Q4 2025, with the low at $5.8 million in Q2 2026.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Debt (Qtr)
1	Abbott Laboratories	180.08 Bn	174.48 Bn	7.27 Bn	29.60 Bn
2	Intuitive Surgical	127.86 Bn	122.64 Bn	1.96 Bn	-
3	Medtronic	117.15 Bn	108.33 Bn	6.34 Bn	25.62 Bn
4	Stryker	103.82 Bn	100.34 Bn	4.50 Bn	14.19 Bn
5	Boston Scientific	63.24 Bn	62.70 Bn	3.85 Bn	10.92 Bn
6	Edwards Lifesciences	49.76 Bn	45.51 Bn	1.35 Bn	598.70 Mn
7	Alcon	32.95 Bn	31.49 Bn	1.68 Bn	-1.00 Mn
8	Dexcom	32.22 Bn	30.27 Bn	830.00 Mn	-
9	Steris	20.71 Bn	20.23 Bn	684.20 Mn	1.65 Bn
10	electroCore	86.61 Mn	76.57 Mn	8.18 Mn	5.77 Mn

Historic Data

Download Data